Intervention Protocol

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

  1. Mario Cruciani1,*,
  2. Arturo J Martí-Carvajal2,
  3. Carlo Mengoli3,
  4. Giovanni Serpelloni1,
  5. Chiara Bovo4,
  6. Graeme Moyle5

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 9 NOV 2011

DOI: 10.1002/14651858.CD009390


How to Cite

Cruciani M, Martí-Carvajal AJ, Mengoli C, Serpelloni G, Bovo C, Moyle G. Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD009390. DOI: 10.1002/14651858.CD009390.

Author Information

  1. 1

    G. Fracastoro Hospital, San Bonifacio, Center of Preventive Medicine & HIV Outpatient Clinic, Verona, Italy

  2. 2

    Universidad de Carabobo and Iberoamerican Cochrane Network, Valencia, Edo. Carabobo, Venezuela

  3. 3

    Università di Padova, Department of Histology, Microbiology and Medical Biotechnology, PADOVA, Italy

  4. 4

    Azienda ULSS 20, Direzione Sanitaria, Verona, Italy

  5. 5

    Chelsea and Westminster Hospital, Department of HIV and Genitourinary Medicine, London, UK

*Mario Cruciani, Center of Preventive Medicine & HIV Outpatient Clinic, G. Fracastoro Hospital, San Bonifacio, Via Germania, 20, Verona, 37135, Italy. crucianimario@virgilio.it.

Publication History

  1. Publication Status: New
  2. Published Online: 9 NOV 2011

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the clinical effectiveness and safety of the combined Antiretroviral Treatment containing ABC relative to ABC-sparing cART. A subgroup comparison will be performed in studies comparing Antiretroviral Treatment containing ABC relative to TDF containing cART.